Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4/A Registration of securities (foreign)
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 5.1 Exhibit 5.1
- 8.1 Exhibit 8.1
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.10 Exhibit 10.10
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
Associated filings
- 19 Jul 22 25-NSE Exchange delisting
- 4 Oct 21 EFFECT Notice of effectiveness
- 1 Oct 21 POS AM Prospectus update (post-effective amendment)
- 8 Mar 21 424B3 Prospectus supplement
- 26 Feb 21 EFFECT Notice of effectiveness
- 26 Feb 21 424B3 Prospectus supplement
- 24 Feb 21 F-4/A Registration of securities (foreign) (amended)
- 19 Feb 21 F-4/A Registration of securities (foreign) (amended)
- 16 Feb 21 F-4/A Registration of securities (foreign) (amended)
-
28 Jan 21 F-4/A Registration of securities (foreign) (amended)
- 8 Jan 21 F-4/A Registration of securities (foreign) (amended)
- 25 Nov 20 F-4 Registration of securities (foreign)
LBPSW similar filings
Filing view
External links
Exhibit 23.2
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of 4D Pharma on Amendment No. 2 to Form F-4 [File No. 333-250986], of our report dated April 30, 2020, with respect to our audits of the financial statements of Longevity Acquisition Corp. as of February 29, 2020 and February 28, 2019 and for year ended February 29, 2020 and for the period from March 9, 2018 (inception) through February 28, 2019, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
January 27, 2021